HIFs (Hypoxia-inducible factors) are transcription factors that respond to changes in available oxygen in the cellular environment, to be specific, to decreases in oxygen, or hypoxia. The HIF signaling cascade mediates the effects of hypoxia, the state of low oxygen concentration, on the cell. Hypoxia often keeps cells from differentiating. However, hypoxia promotes the formation of blood vessels, and is important for the formation of a vascular system in embryos, and cancer tumors. The hypoxia in wounds also promotes the migration of keratinocytes and the restoration of the epithelium. In general, HIFs are vital to development. In mammals, deletion of the HIF-1 genes results in perinatal death. HIF-1 has been shown to be vital to chondrocyte survival, allowing the cells to adapt to low-oxygen conditions within the growth plates of bones. HIF plays a central role in the regulation of human metabolism. Recently, several drugs that act as selective HIF prolyl-hydroxylase inhibitors have been developed.
IOX4 是一种选择性 PHD2 抑制剂,IC50 值为 1.6 nM,通过与 PHD2 活性位点的 2-氧代戊二酸 (2OG) 竞争并置换该辅因子,在细胞和野生型小鼠中诱导 HIFα 表达,并可通透血脑屏障。
PT2399 是一种高效、选择性的 HIF-2α 拮抗剂,可直接结合 HIF-2α PAS B 结构域,IC50 值为 6 nM,并具有高效的体内抗肿瘤活性。
PT2399 (Standard) 是 PT2399 (MS-C60409) 的分析标准品,可用于研究及分析应用;PT2399 是一种高效、选择性的 HIF-2α 拮抗剂,能直接结合 HIF-2α PAS B 结构域,IC50 值为 6 nM,并具有高效的体内抗肿瘤活性。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号